Microsoft and Eli Lilly are two of the most overbought stocks as the first half comes to a close

Welcome to Extreme Investor Network, where we provide you with unique insights and valuable information to help you make informed investment decisions. As we wrap up the first half of the year, it’s important to take a closer look at the current market trends and identify potential opportunities for both gains and pullbacks.

The first half of the year has been marked by significant gains across the board, with all three major indexes on track to end with positive returns. The S&P 500 has seen a 15% increase, the Dow Jones Industrial Average is up 5%, and the Nasdaq Composite has outperformed with a 20% gain. This growth has been largely driven by the rise of companies like Nvidia, which recently hit a $3 trillion market valuation, and Microsoft, which has surged nearly 21% this year.

Related:  The Stocks that are already in a correction and may experience further declines

However, as we head into the second half of the year, some stocks may be in for a pullback. CNBC Pro recently screened the S&P 500 for overbought names, including Microsoft, Eli Lilly, and FedEx. These companies have seen strong gains in 2024, but their 14-day relative strength index (RSI) suggests they may be due for a downturn in the near term. On the other hand, there are oversold stocks like Walgreens Boots Alliance and Waters Corporation, which may be primed for a rebound.

For example, Eli Lilly has climbed nearly 57% this year, driven in part by the success of its GLP-1 drugs and Alzheimer’s and diabetes medications. On the other hand, Walgreens has faced challenges due to a tough macroeconomic environment, but analysts see potential for a significant upside in the near future.

Related:  One expert raises concerns about the recent resurgence of meme stocks

At Extreme Investor Network, we keep a close eye on market trends and provide you with valuable insights to help you navigate the ever-changing investment landscape. Stay tuned for more updates and analysis to help you maximize your investment potential.

Source link